CLONED HUMAN CD8(-LYMPHOCYTES PROTECT HUMAN PERIPHERAL-BLOOD LEUKOCYTE-SEVERE COMBINED IMMUNODEFICIENT MICE FROM HIV-1 INFECTION BY AN HLA-UNRESTRICTED MECHANISM() CYTOTOXIC T)
R. Vankuyk et al., CLONED HUMAN CD8(-LYMPHOCYTES PROTECT HUMAN PERIPHERAL-BLOOD LEUKOCYTE-SEVERE COMBINED IMMUNODEFICIENT MICE FROM HIV-1 INFECTION BY AN HLA-UNRESTRICTED MECHANISM() CYTOTOXIC T), The Journal of immunology, 153(10), 1994, pp. 4826-4833
The ability to infect human peripheral blood leukocyte-reconstituted s
evere combined immunodeficient (hu-PBL-SCID) mice with HIV has allowed
evaluation of several strategies for preventing or treating infection
. In one study, hu-PBL-SCID mice derived from HIV gp160-vaccinated don
ors were shown to resist HIV infection, and resistance correlated best
with in vitro assays of cellular immunity. We have assessed directly
the importance of cellular immunity to HIV in the present experiments
by the adoptive transfer of HLA-A3-restricted HIV-1 Nef-specific or HL
A-B14-restricted Gag-specific CD8(+) CTL clones to SCID mice bearing H
LA-matched or mismatched PBL grafts. Multiple inoculations of CTL befo
re and after HIV-1 exposure protected HLA-matched hu-PBL-SCID mice fro
m infection, but initiation of CTL therapy on the same day as HIV infe
ction was much less effective. However, at the high numbers of CTL req
uired for complete protection from HIV infection, many HLA-mismatched
hu-PBL-SCID mice were also protected by pre-exposure CTL transfer. Tra
nsfer of CTL with a different specificity (HTLV-1 Tax) to HLA-matched
hu-PBL-SCID mice also afforded partial protection. These results sugge
st that HLA-restricted cytotoxicity may be less important than other n
onspecific effector mechanisms for the inhibition of HIV-1 infection i
n vivo.